MedPath
FDA Approval

Tavaborole

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Chartwell RX, LLC
DUNS: 079394054
Effective Date
September 15, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Tavaborole(43.5 mg in 1 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Tavaborole

Product Details

NDC Product Code
62135-663
Application Number
ANDA211963
Marketing Category
ANDA (C73584)
Route of Administration
TOPICAL
Effective Date
September 15, 2023
ALCOHOLInactive
Code: 3K9958V90MClass: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
EDETATE CALCIUM DISODIUMInactive
Code: 25IH6R4SGFClass: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
Code: K124A4EUQ3Class: ACTIBQuantity: 43.5 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath